Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome

Myelodysplastic syndrome (MDS) is a heterogeneous, clonal hematological disorder characterized by ineffective hematopoiesis, cytopenia, morphologic dysplasia, and predisposition to acute myeloid leukemia (AML). Stem cell genomic instability, microenvironmental aberrations, and somatic mutations cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Paul, Yim, Rita, Yung, Yammy, Chu, Hiu-Tung, Yip, Pui-Kwan, Gill, Harinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508686/
https://www.ncbi.nlm.nih.gov/pubmed/34638574
http://dx.doi.org/10.3390/ijms221910232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508686/
https://www.ncbi.nlm.nih.gov/pubmed/34638574
http://dx.doi.org/10.3390/ijms221910232

Ejemplares similares